|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 AUD | -3.77% |
|
-20.31% | -10.53% |
| 05-28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
| 05-28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
Opthea Limited, at its EGM held on April 21, 2022, approved the election of Susan C Orr and Quinton Oswald as directors of the company.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.53% | 224M | |
| +43.36% | 54.63B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B |
OPTHEA LIMITED 
